New Immune-Focused Therapy Shrinks Aggressive Brain Tumors
THURSDAY, March 14, 2024 (HealthDay News) — Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient’s spinal fluid quickly shrank deadly brain tumors, researchers report. CAR T therapy harnesses the power of the patient’s immune system T-cells, which are reprogrammed to seek and destroy a specific protein found onContinue Reading










